Skip to Content

SHARE

Clinical Trials Details

Myocardial Infarction

Do you have heart disease and are currently recieving antiplatelet therapy (blood thinning medications)?

Objective

ARTEMIS: Affordability and real-world antiplatelet treatment effectiveness after myocardial infarction study.

 

The purpose of this study is to learn more about how long patients take antiplatelet medications after hospital discharge, and how this influences patients' long-term health and use of healthcare resources.

Approximately 11,000 patients will take part in this study at approximately 300 different hospitals and medical facilities around the United States.

IRB Protocol Number
D5130R0030
Principal Investigator(s)
Brian Rah, MD
Sponsor(s)
AstraZeneca
Contact
Recruitment Hotline at 406-657-4111
or research@billingsclinic.org

Location

  • Billings Clinic Hospital Fountain Courtyard - South of the Hospital Cafeteria
    2750 9th Ave North
    Billings, MT 59101